Turnover increases by 30 percent - user studies with 400 participants
Hennigsdorf b. Berlin, 20 July 2023 – Despite inflation and the energy crisis, the biotechnology pioneer BELANO medical AG closed the past financial year with an increase in sales of around 30 percent. Particularly in the B2B business, where the company prepares natural microbiotic active ingredients and provides formulations for other brand labels, the demand has risen sharply over the course of 2022. „This trend has fortunately continued in the first half of 2023“, says Dr. Bernd Wegener, CEO of BELANO medical.
In addition to the existing corporate business with well-known German companies from the pharmaceutical and cosmetics industry, further, mainly international customers have been added in the past 18 months, including from the Netherlands, Ukraine, Spain, Poland and Switzerland. This positive development is in line with the goals of the corporate strategy, which was geared towards internationalization and expansion of the business customer business as well.
In the end BELANO medical was able to increase sales in the past and current financial year with its customer business via direct sales and sales via online pharmacies. „One reason for this is certainly the high level of attention we were able to achieve with two user studies“, explains Prof. Dr. Christine Lang, Director of Research and Development. Around 400 persons participated in the two studies, which substantiate the effectiveness of the active ingredients “ibiotics stimulans” (e.g. for atopic dermatitis, rosacea and other skin diseases) and “ventrisana” (inflammations in the mouth such as periodontitis or Helicobacter and other inflammatory diseases) developed and marketed by BELANO medical.
The user study to investigate the active substance in atopic dermatitis was conducted in 2022 in cooperation with the German Atopic Dermatitis Association. The study on the prevention of periodontal disease and bleeding gums was completed in June 2023, the evaluation will be completed shortly. „In both studies, we were able to achieve very positive results and demonstrate a very high degree of effectiveness of our products“, says Prof. Lang. In consequence, the participating patients expressed a very high level of satisfaction and frequently recommended the active ingredients and products “ibiotics” and “ibiotics med” as well as “ventrisana”. „We can see the high recommendation rate directly in the sales figures“, states Lang.